International Lyme And Associated Diseases Society
Leaders in Lyme Disease Education and Training
Donate to ILADS Now
Join ILADS Now
  1. ILADS Officers and Directors
  2. ILADEF Officers

ILADS Officers

Daniel J. Cameron, MD, MPH

{ President }

Daniel Cameron, MD graduated from the University of Minnesota followed by residencies at Beth Israel Medical Center and Mt. Sinai School of Medicine in New York. Dr. Cameron is widely recognized for conducting epidemiologic research while practicing medicine. He has been viewed as a pioneer in Lyme disease as an author of practice guidelines, analytic reviews, and clinical trials. He has published 9 peer reviewed articles based on his research in the past 5 years.

Dr. Cameron has led ILADS, the International Lyme and Associated Diseases Society, to new heights as its president from 2007 to 2009. He has testified as an expert on Lyme disease for legislation in Connecticut, Massachusetts, and Pennsylvania for physician's rights to diagnose Lyme disease using clinical judgment without state interference. He has been interviewed as an expert on the NBC today show, Good Morning America, Fox News, Sirius radio and in newspapers.

He currently sees patients in his private practice in Mt. Kisco, New York while continuing his research and writing. He maintains the website www.LymeProject.com.

Raphael Stricker, MD

{ President-Elect }

Dr. Stricker received his medical degree and training in Internal Medicine at Columbia University in New York. He did subspecialty training in Hematology/Oncology at the University of California San Francisco, and supplemental training in Immunology and Immunotherapy at California Pacific Medical Center in San Francisco. He is currently the Medical Director of Union Square Medical Associates, a multispecialty medical practice in San Francisco (Website: www.usmamed.com).

Daniel A. Kinderlehrer, MD

{ Secretary }

Daniel A. Kinderlehrer, MD is a nationally recognized holistic physician with expertise in the fields of nutrition, allergy, environmental medicine, Lyme disease and the healing of mind-body-spirit as a unified whole. Dr. Kinderlehrer co-founded The New England Center for Holistic Medicine in Newbury MA, and has taught extensively, including practitioner training courses at the National Institute of Behavioral Medicine and The Omega Institute. He coauthored The Antioxidant Save-Your-Life Cookbook and is the author of several review articles in medical journals and the Lyme Times. His integrated medical practice in Boulder, CO focuses on the diagnosis and treatment of tick-borne disease.

Samuel M. Shor, MD, FACP

{ Treasurer }

Samuel Shor, MD, FACP; Associate Clinical Professor, George Washington University Health Care Sciences. Selected four times by his peers as a Washingtonian TOP DOCTOR, Dr. Shor has also been selected by Best Doctors.com and Washington Consumer's Checkbook as a top Primary Care Physician. Dr. Shor developed his long standing interest in chronic fatigue in the late 1980s. He subsequently developed an interest in managing associated conditions such as fibromyalgia and ultimately led to his interest in Lyme disease. A congressional presentation of Lyme disease on Capitol Hill 9/24/08, an interview on the nationally syndicated Diane Rehm Show [4/20/09] and an invitation to participate in the 2010 Virginia Governor's Task Force on Lyme disease are examples of Dr Shor's strong interest in educating the public. He continues to be actively involved in patient care while pursuing his interests in clinical research and publishing in the peer review literature. Further information about Dr. Shor can be viewed at his web site: www.intmednova.com

Leo J. Shea, III, PhD

{ Immediate Past President }

Leo J. Shea III, Ph.D. is Clinical Associate Professor of Rehabilitation Medicine at Rusk Institute, a division of the New York University-Langone Medical Center. Dr. Shea is also President of Neuropsychological Evaluation and Treatment Services, P.C. with offices in New York City and Quincy, Massachusetts. His practice focuses on tick-borne diseases, traumatic brain injury, chronic illness and trauma and provides cognitive remediation and psychotherapy to individuals and families. He is Chairman Emeritus of the National Research Fund for Tick-borne Diseases, Inc. which funds scientific research at major medical and academic institutions. He also serves on the Scientific and Community Advisory Board for the study of Lyme disease at Stanford University Medical Center. www.LeoShea.com.

ILADS Directors

Christine Green, MD

Christine Green, MD is a Phi Beta Kappa graduate of Reed College in Biology and Ecology, an appropriate choice for a doctor treating tick borne diseases. She completed her medical training at UC San Diego and then went on to her family practice residency at Stanford University. Dr. Green works at Green Oaks Medical Center in Los Altos, CA. She is the Chair of the ILADS Medical Education Committee.

Judith G. Leventhal, PhD

Judith G. Leventhal, Ph.D. is a New York State Licensed Psychologist with specialties in Clinical Psychology, Neuropsychology and Family Therapy. Her areas of interest and expertise include neurological disorders, traumatic brain injury, tick borne diseases, learning and language disabilities, trauma and loss and individual and family resilience. She is an authority on the neuropsychological manifestations of Lyme and associated tick borne diseases and the impact of cognitive, emotional and behavioral symptoms on academic and interpersonal functioning. Her neuropsychological evaluations form the basis for the development of appropriate academic accommodations and modifications and she works with schools to advocate for children with tick borne diseases. Dr. Leventhal has presented her work at numerous professional conferences, lectured to many advocacy groups, serves on the Board of Directors of the International Lyme and Associated Diseases Society and Chairs the ILADS Membership Committee. She has held positions in the neurology departments of several New York City teaching hospitals and maintains a private practice in New York City.

Kenneth B. Liegner, MD

Dr. Kenneth Liegner is a Board Certified Internist with additional training in Pathology and Critical Care Medicine, practicing in Pawling, New York. He has been actively involved in diagnosis and treatment of Lyme disease and related disorders since 1988. He has published articles on Lyme disease in peer-reviewed scientific journals and has presented poster abstracts and talks at national and international conferences on Lyme disease and other tick-borne diseases. He has cared for many persons seriously ill with chronic and neurologic Lyme disease. His work has focused on the serious morbidity and (occasional) mortality that can eventuate from this aspect of the illness. He has emphasized the urgent need for widespread clinical availability of improved methods of diagnostic testing and for development of improved methods of treatment for Lyme disease in all its stages. He holds the first United States patent issued proposing application of acaricide to deer for area-wide control of deer-tick populations as a means of reducing the incidence of Lyme disease.

Thomas Moorcroft, DO

Tom did his undergraduate studies at the University of Vermont before attending the University of New England College of Osteopathic Medicine (UNECOM). While at UNECOM, Tom was selected to complete a one year fellowship in Osteopathic Manipulative Medicine. Tom completed his residency training in Family Medicine at Middlesex Hospital in Middletown, CT. Tom deeply believes that the true source of radiant health is within each of us. Dr. Tom has been fortunate to have many amazing mentors, including Mark Rosen, DO, Eric Dolgin, DO, Michael Burruano, DO, Andrew Goldman, DO, Richard Horowitz, MD, and Charles Ray Jones, MD. He recently has had the opportunity to participate in intensives with Deitrich Klinghardt, MD and Ritchie Shoemaker, MD. Currently, Dr. Tom is the only fully licensed physician in the State of Connecticut to have completed the International Lyme and Associated Diseases Society's Physicians Training Program. View his website at: www.originsofhealth.com

Armin Schwarzbach, MD, PhD

Dr. Armin Schwarzbach, MD, PhD is a specialist in laboratory medicine from the Borreliose Centrum Augsburg/Infectolab, Augsburg, Germany. He began by studying biochemistry at Hoechst AG, Frankfurt/Germany and pharmacy at the University of Mainz/Germany in 1984. After that he studied medicine for 6 years at the University of Mainz/Germany and finished his MD in 1991. He worked as a medical assistant in internal medicine, oncology, cardiology, gastroenterology and infectiology afterwards for several years. By 1993 he had started specializing in laboratory medicine for another 4 years in infectiology, microbiology, immunology, hematology, clinical chemistry, endocrinology and gynecological endocrinology.

Dr. Schwarzbach is the Chair of the laboratory test, international and international membership committees of ILADS and was appointed in March 2013 as the International expert for the Chief Medical Officers Clinical Advisory Committee on Lyme Disease in Australia (CACLD) of the Australian Government, Department of Health and Ageing, Canberra, Australia. He is also member of the new working group for Lyme disease of the Haut Conseil de la sante publique, Paris, France.

Dr. Schwarzbach is member of the German Borreliosis Society, the Swiss Association for Tick-borne diseases, the German Association of Clinical Chemistry and Laboratory Medicine, the German Society for Medical Laboratory Specialists and the Australasian Integrative Medicine Association.

Dr. Schwarzbach developed the first worldwide Radioimmunoassay for human Gastric Inhibitory Polypeptide. He is the co-founder and CEO of the Borreliose Centrum Augsburg and Infectolab laboratories in Augsburg/Germany and specializes in the diagnostics and treatment for patients with tick-borne diseases for over 10 years now.

ILADEF Officers

Leo J. Shea, III, PhD

{ President }

Leo J. Shea III, Ph.D. is Clinical Assistant Professor of Rehabilitation Medicine at Rusk Institute, a division of the New York University Langone Medical Center. Prior to his present work with tick-borne and immunological disorders, he was Assistant Director of the NYU Brain Injury Day Treatment Program. Apart from his academic and clinical responsibilities at NYU Langone Medical Center, Dr. Shea is also President of Neuropsychological Evaluation and Treatment Services, P.C. with offices in New York City and Quincy, Massachusetts. His practice focuses on tick-borne diseases, traumatic brain injury, chronic illness, trauma and disaster management and provides cognitive remediation and psychotherapy to individuals and families. Dr. Shea has served as an organizational consultant to national and international corporations on human resources, administrative and executive training and development, trauma response and health care issues. His clients have included both political and public institutions such as the United Nations Development Program.

Carsten Nicolaus, MD, PhD

{ Treasurer }

Dr. Carsten Nicolaus started his medical training in1981 at the University of Regensburg (Bavaria/Germany) and received his medical degree in 1988 at the Technical University of Munich (Klinikum Rechts der Isar). In 1989 he received his PhD in Transplantation Immunology.

Dr. Nicolaus is treating Lyme patients since 1990. Over the past 20 years he has become a well recognized specialist in diagnosis and treatment of Lyme and other associated chronic infectious diseases in Germany and Europe.

Since 2006 Dr. Nicolaus is the Medical and Executive Director of the BCA-clinic (www.b-c-a.de) specialized in diagnosis, treatment and rehabilitation of Lyme and co-infected patients. Another special focus of his work is Pain Management and Chronic Fatigue.

Dr. Nicolaus is a member of ILADS and the German Borreliosis Society (www.borreliose-gesellschaft.de) and also acts as an active Board Member of the International Lyme and Associated Disease Educational Foundation (ILADEF). He also is a member of the Medical Advisory Board of the Charles E. Holman Foundation (CHEF) and several other medical and scientific organizations.

ILADEF Directors

Robert C. Bransfield, MD

Robert C. Bransfield, MD, DLPAPA is a graduate of Rutgers College and the George Washington University School of Medicine. He completed his psychiatric residency training at Sheppard and Enoch Pratt Hospital. He is board certified by the American Board of Psychiatry and Neurology in Psychiatry, is certified in Clinical Psychopharmacology by the American Society of Clinical Psychopharmacology and is Distinguished Life Fellow of the American Psychiatric Association.

Dr. Bransfield's primary activity is an office based private practice of psychiatry. In addition, Dr. Bransfield is the Associate Director of Psychiatry and Chairman of Psychiatric Quality Assurance at Riverview Medical Center in Red Bank, NJ, Past Immediate President of the International Lyme and Associated Diseases Society, Immediate President of the New Jersey Psychiatric Association. He has held a number of administrative positions for various organizations involved with a number of health, mental health and community related activities.

Joseph J. Burrascano, Jr., MD

Joseph J. Burrascano Jr. MD is a well recognized specialist in the diagnosis and treatment of Lyme and associated complex infectious diseases, and the chronic illnesses that accompany them. With over two decades of experience and research in this field, he has appeared in and on virtually every form of media, has advised the CDC and NIH, testified before the U.S. Senate, an armed services joint subcommittee, and at various governo's councils. A founding member of ILADS, he currently is an active Board Member of the International Lyme and Associated Diseases Educational Foundation. His current areas of interest include his ongoing project, The Lyme and Associated Diseases Registry™ which follows each selected patient from the beginning to the end of their illness, to try to divine out what the various symptoms mean, which tests are worthwhile, to identify the medications and treatments that have the highest likelihood of curing the illness, and to uncover any possible drawbacks to treatment. In addition, he is actively involved in study of the newly discovered retrovirus, HGV, thought to be associated with chronic neuroimmune diseases, including chronic Lyme. Finally, his lifelong interest in nutrition has come to bear with his present consultative work with various nutritional supplement suppliers. No longer in clinical practice, Dr. Burrascano works full time in the biotech arena to further medical research in tick-borne and other chronic illnesses.

Daniel J. Cameron, MD, MPH

Daniel Cameron, MD graduated from the University of Minnesota followed by residencies at Beth Israel Medical Center and Mt. Sinai School of Medicine in New York. Dr. Cameron is widely recognized for conducting epidemiologic research while practicing medicine. He has been viewed as a pioneer in Lyme disease as an author of practice guidelines, analytic reviews, and clinical trials. He has published 9 peer reviewed articles based on his research in the past 5 years.

Dr. Cameron has led ILADS, the International Lyme and Associated Diseases Society, to new heights as its president from 2007 to 2009. He has testified as an expert on Lyme disease for legislation in Connecticut, Massachusetts, and Pennsylvania for physician's rights to diagnose Lyme disease using clinical judgment without state interference. He has been interviewed as an expert on the NBC today show, Good Morning America, Fox News, Sirius radio and in newspapers.

He currently sees patients in his private practice in Mt. Kisco, New York while continuing his research and writing. He maintains the website www.LymeProject.com.

Nick S. Harris, PhD

Dr. Nick Harris, a board certified immunologist, is currently the President and CEO of IGeneX Laboratory, which he founded in 1991. His undergraduate training was at the Univ. of Wisconsin and graduate training at the Medical Center, Univ. of Illinois, in Chicago. Following a postdoctoral fellowship in transplantation immunology at the Univ. of Minnesota, he became an Associate Professor of Surgery and Biochemistry at the Univ. of Texas. He left academia to head the immunology department at Bioscience Laboratories in Los Angeles, then joined 3M Diagnostic Systems as Technical Director. Dr. Harris has three patents, over 100 formal publications in immunology and Lyme disease, and three book chapters. He helped found ILADS in 1999 and is an active member of numerous societies. He is on the Board of Directors of CALDA and of the International Lyme and Associated Disease Society.

Carsten Nicolaus, MD, PhD

Dr. Carsten Nicolaus started his medical training in1981 at the University of Regensburg (Bavaria/Germany) and received his medical degree in 1988 at the Technical University of Munich (Klinikum Rechts der Isar). In 1989 he received his PhD in Transplantation Immunology.

Dr. Nicolaus is treating Lyme patients since 1990. Over the past 20 years he has become a well recognized specialist in diagnosis and treatment of Lyme and other associated chronic infectious diseases in Germany and Europe.

Since 2006 Dr. Nicolaus is the Medical and Executive Director of the BCA-clinic (www.b-c-a.de) specialized in diagnosis, treatment and rehabilitation of Lyme and co-infected patients. Another special focus of his work is Pain Management and Chronic Fatigue.

Dr. Nicolaus is a member of ILADS and the German Borreliosis Society (www.borreliose-gesellschaft.de) and also acts as an active Board Member of the International Lyme and Associated Disease Educational Foundation (ILADEF). He also is a member of the Medical Advisory Board of the Charles E. Holman Foundation (CHEF) and several other medical and scientific organizations.

Raphael Stricker, MD

Dr. Stricker received his medical degree and training in Internal Medicine at Columbia University in New York. He did subspecialty training in Hematology/Oncology at the University of California San Francisco, and supplemental training in Immunology and Immunotherapy at California Pacific Medical Center in San Francisco. He is currently the Medical Director of Union Square Medical Associates, a multispecialty medical practice in San Francisco (Website: www.usmamed.com).